Wockhardt (Mid Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Wockhardt Limited |
|||
|
Price: ₹1,430.10 (+10%) | ||
| 52 Week Low: ₹415.30 52 Week High: ₹1,582.95 |
|||
| Market Capital: 8,648.75 Crore (Midcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Wockhardt Share Price Target For 2025
- 1.1.1: Wockhardt Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Wockhardt Share Price Target For 2026
- 1.2.1: Wockhardt Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Wockhardt Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Wockhardt Brief Company Overview
- 4: Wockhardt Financial Performance
- 4.0.1: Is Wockhardt A Good Buy For Long Term?
Wockhardt, a Mid Cap company in the Drug Manufacturers - Specialty & Generic Industry has delivered 299.4% returns in 5-year showing 0.3% quarterly revenue growth, making it a potential Multibagger.
To predict the Wockhardt's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Wockhardt Share Price Target For 2025
The line chart displays the monthly closing prices of Wockhardt with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Wockhardt shares in 2025, see the table below.
Wockhardt Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1737.27 (+21.47%) | Price Action: Chart |
| 2025 Target 2 | 1704.88 (+19.21%) | Price Action: Chart |
| 2025 Target 1 | 1688.0 (+18.03%) | Fibonacci Extension Level 23.60% |
| Current Price | 1430.10 | Wockhardt's share price as of 23 Jan 2025 |
| Stop Loss 1 | 1353.6 (-5.35%) | Price Action: 27 Nov 2024 High |
| Stop Loss 2 | 1340.0 (-6.31%) | Price Action: 28 Nov 2024 Low |
| Stop Loss 3 | 1325.05 (-7.35%) | Price Action: 21 Jan 2025 Low |
Short-Term Technical Outlook
Current Technical Position: Wockhardt is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹1422.02 serves as the nearest technical reference point.
Historical Returns: 3-month: +7.59% | 6-month: +40.92% | 1-year: +182.48%
Wockhardt Share Price Target For 2026
The line chart displays the monthly closing prices of Wockhardt with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Wockhardt shares in 2026, see the table below.
Wockhardt Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 2363.23 (+65.23%) | Fibonacci Extension Level 64.90% |
| 2026 Target 2 | 2324.87 (+62.56%) | Price Action: Chart |
| 2026 Target 1 | 2301.85 (+60.95%) | Fibonacci Extension Level 150.00% |
| Current Price | 1430.10 | Wockhardt's share price as of 23 Jan 2025 |
| Stop Loss 1 | 1216.0 (-14.98%) | Price Action: 11 Nov 2024 Low |
| Stop Loss 2 | 1202.55 (-15.92%) | Price Action: 21 Nov 2024 High |
| Stop Loss 3 | 1184.35 (-17.19%) | Price Action: 18 Nov 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Wockhardt is currently trading near its 52-week high of ₹1582.95, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +182.48% | 3-year: +258.14% | 5-year: +299.37%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Wockhardt Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,430.10 | ||
| 2025 | ₹2,200.30 | +53.85% | ₹2,233.30 |
| 2026 | ₹2,779.62 | +26.32% | ₹2,821.31 |
| 2027 | ₹3,830.96 | +37.82% | ₹3,888.42 |
| 2028 | ₹5,080.26 | +32.61% | ₹5,156.46 |
| 2029 | ₹7,148.04 | +40.7% | ₹7,255.26 |
| 2030 | ₹9,185.54 | +28.5% | ₹9,323.32 |
| 2031 | ₹12,124.89 | +31.99% | ₹12,306.76 |
| 2032 | ₹16,195.14 | +33.56% | ₹16,438.07 |
| 2033 | ₹20,085.81 | +24.02% | ₹20,387.10 |
| 2034 | ₹25,547.16 | +27.19% | ₹25,930.37 |
| 2035 | ₹32,135.12 | +25.78% | ₹32,617.15 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Wockhardt Brief Company Overview
Wockhardt: A Pharmaceutical Giant Wockhardt, established in 1967, is a renowned pharmaceutical and biotech company with a global reach. Headquartered in Mumbai, India, the company manufactures and markets a wide range of pharmaceuticals, medicinal, and chemical products in over...
15 countries. Wockhardt's diverse product portfolio includes generic and branded formulations, injectables, biosimilars, vaccines, active pharmaceutical ingredients, and contract manufacturing services. The company's commitment to research and development has resulted in a robust pipeline of innovative molecules, particularly in the areas of infectious diseases and diabetes management. Wockhardt has built a strong reputation in the industry for its high-quality products, affordable pricing, and commitment to patient care.Wockhardt Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 8,648.75 Crore | Market valuation of Wockhardt's shares. |
| Revenue (TTM) | 2,776 Crore | Total revenue generated by Wockhardt over the past twelve months. |
| Net Income (TTM) | -500.99 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -0.43% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -18.05% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+0.3% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
66.25 | Company's total debt divided by total shareholder equity. |
| Total Debt | 2,274 Crore | Sum of Wockhardt's current & long-term financial obligations. |
| Total Cash | 115 Crore | Total amount of liquid funds available to Wockhardt. |
| Beta | 1.62 | Beta is greater than 1 indicating that the Wockhardt's price is more volatile than the market. |
Is Wockhardt A Good Buy For Long Term?
Wockhardt's financial performance has been volatile, with a recent net loss and a high debt-to-equity ratio. While its revenue growth is modest, its profit margin remains negative. Despite recent returns, the company's long-term growth prospects are uncertain. Therefore, it may not be a suitable buy for long-term investors seeking consistent returns.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
